MktsMarkets

Axsome Therapeutics, Inc.
NASDAQ: AXSMKey statistics
AXSM News
Stories mentioning AXSM from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 191,203 | 195,999 | 170,992 | 150,042 | 121,463 | 118,766 | 104,762 | 87,166 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | 52,677 | 48,791 | 40,162 | 49,541 | 44,785 | 55,006 | 45,388 | 49,853 |
| Sales General & Admin | 184,996 | 169,297 | 150,235 | 130,280 | 120,787 | 113,271 | 95,564 | 103,554 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (63,357) | (26,957) | (46,109) | (36,714) | (56,982) | (72,617) | (62,624) | (78,046) |
| Interest Income | ||||||||
| Interest Expense | 3,092 | (13,725) | (3,375) | (4,086) | 5,258 | (5,430) | (5,666) | (5,079) |
| Other Expense | ||||||||
| Pretax Income | (64,542) | (28,129) | (47,229) | (48,933) | (59,413) | (74,827) | (64,602) | (79,345) |
| Tax Provision | 0.00 | 430.00 | 0.00 | (960.00) | 0.00 | 85.00 | 0.00 | 0.00 |
| Net Income (Loss) | (64,542) | (28,559) | (47,229) | (47,973) | (59,413) | (74,912) | (64,602) | (79,345) |
| Earnings Per Share (Basic) | (1.26) | (0.57) | (0.94) | (0.97) | (1.22) | (1.56) | (1.34) | (1.67) |
| Earnings Per Share (Diluted) | (1.26) | (0.57) | (0.94) | (0.97) | (1.22) | (1.56) | (1.34) | (1.67) |
| Weighted Average Shares Outstanding (Basic) | 51,198 | 49,747 | 50,022 | 49,442 | 48,871 | 47,914 | 48,141 | 47,573 |
| Weighted Average Shares Outstanding (Diluted) | 51,198 | 49,747 | 50,022 | 49,442 | 48,871 | 47,914 | 48,141 | 47,573 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About AXSM
Axsome Therapeutics, Inc. (NASDAQ: AXSM) is a stock listed on the Nasdaq Stock Market under the ticker symbol AXSM. It last traded at $129.36 (Nov 20, 2026, 4:00 PM ET), down 4.7% on the day. That gives Axsome Therapeutics a market capitalisation of $6.9B.
Over the past 52 weeks AXSM has traded between $123.00 and $260.19.
Revenue for the quarter ended Mar 31, 2026 was $191.2M; a net loss of $64.5M. Revenue was up 57.4% from $121.5M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $191.2M | -$64.5M | -33.8% |
| Dec 31, 2025 | $196.0M | -$28.6M | -14.6% |
| Sep 30, 2025 | $171.0M | -$47.2M | -27.6% |
| Jun 30, 2025 | $150.0M | -$48.0M | -32.0% |
From Axsome Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…